Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Latham BioPharm Group Expands Offering into Digital Health
Latham BioPharm Group (LBG), part of Sia Partners, is excited to announce the addition of a […]
Indivumed Evolves into Indivumed Therapeutics to Focus on Data and AI-Driven Advancement of Precision Oncology
After twenty years as one of the first personalized oncology companies, Indivumed today announced its […]
Medtronic to Boost AI Innovation with New Platform Introduction
Medtronic, a global leader in healthcare technology, has announced Cosmo Pharmaceuticals and NVIDIA plan to […]
Lunit Meets MDR CE Requirements for 3D Breast Tomosynthesis AI Solution
Lunit, a leading global provider of AI-powered cancer solutions, today announced that its AI solution […]
Antiverse Raises Funding and Demonstrates Therapeutic Antibody Identification with AI-driven Drug Discovery Platform
Antiverse Ltd, a biotechnology company developing a computational antibody drug discovery platform, has announced the […]
UltraSight Granted Patent for Real-Time Guidance Ultrasound Technology
UltraSight, an Israeli-based digital health pioneer transforming cardiac imaging through the power of artificial intelligence, […]
Methinks receives CE Marked Certification for AI-based Stroke Triage Software
Methinks, a digital health Company that specializes in early detection and management of Acute Stroke […]
New AI Tool Makes Speedy Gene Editing Possible
An artificial intelligence (AI) program may enable the first simple production of customizable proteins called […]
PVmed Raises US $14 Million Series A Funding
Perception Vision Medical Technologies (PVmed), a global artificial intelligence (AI) cancer treatment company, headquartered in […]
XtalPi and EDDC Collaborate in AI-empowered Drug Discovery Program for Non-Small Cell Lung Cancer
XtalPi, a pioneering pharmaceutical technology company powered by artificial intelligence (AI) and automation, has announced […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more